Abstract:Objective: Systemic levels of up-regulated IL-1β and IL-1 receptors promote the pathogenesis of inflammation-associated diabetes. IL-1 receptor antagonist (IL-Ra) has shown slightly elevated beta cell function in patients with type 2 diabetes without significant improvement of hyperglycaemia. We investigated whether miR-153, an IL-1β responsive miRNA, could mimic IL-1β effects and whether its interruption would improve blood glucose control then offer an assistant curative approach to inflammation-associated diabetes. Materials/methods: Antago-miR-153 and Ago-miR-153 were injected into the abdominal aorta of leptin receptor-mutant db/db mice and C57BL/6 J mice, respectively. Blood glucose levels, glucose tolerance tests, insulin tolerance tests and insulin levels were regularly checked. Proteomic profiling combined with unbiased bioinformatics analysis, as well as experimental techniques, were utilized to identify target genes of miR-153. Anti-miR-153 and plasmid-based recovery assays were also performed using primary mouse islets and beta cell lines. Results: The miR-153 expression level was increased in IL-1β-treated beta cells and primary islets from the diabetic rodents. Pancreas overexpression of miR-153 caused glucose intolerance in C57BL/6 J mice but no alterations in body weight or insulin sensitivity. The inhibition of miR-153 temporarily reduced hyperglycaemia of db/db mice due to enhanced insulin secretion. Antago-miR-153 treatment ameliorated glucose intolerance in db/db mice during our observation period but did not improve insulin sensitivity. Mechanistically, miR-153 targeted three members of SNAREs to disturb insulin granule docking, thereby decreasing basal insulin secretion. Overexpression of anti-miR-153 or SNARE rescued the IL-1β-induced basal insulin secretion defect. Furthermore, miR-153 targeted beta cell-specific transcriptional factors and survival molecules to inhibit insulin biosynthesis and cell viability. Conclusions: The IL-1β-responsive miR-153 targets SNAREs, beta cell specific TFs and other key factors to eventually causes beta cell failure. Inhibiting miR-153 with Antago-miR-153 prevents hyperglycaemia in db/db mice, indicating that miR-153 may be a promising therapeutic target for the treatment of inflammation-associated diabetes.

Differentially Expressed MicroRNA-483 Confers Distinct Functions in Pancreatic Β- and Α-Cells

MicroRNA-223 is Essential for Maintaining Functional Β-Cell Mass During Diabetes Through Inhibiting Both FOXO1 and SOX6 Pathways

Obesity-induced upregulation of miR-483-5p impairs the function and identity of pancreatic β-cells

MicroRNA-185 targets SOCS3 to inhibit beta-cell dysfunction in diabetes

MicroRNA-15a Positively Regulates Insulin Synthesis by Inhibiting Uncoupling Protein-2 Expression

A pancreatic islet-specific microRNA regulates insulin secretion

Repressing miR-23a promotes the transdifferentiation of pancreatic α cells to β cells via negatively regulating the expression of SDF-1α

Increased Expression of Circulating microRNA 101-3p in Type 1 Diabetes Patients: New Insights Into miRNA-Regulated Pathophysiological Pathways for Type 1 Diabetes

Inhibition of miR-153, an IL-1β-responsive miRNA, prevents beta cell failure and inflammation-associated diabetes

Microrna-19b Downregulates Insulin 1 Through Targeting Transcription Factor Neurod1

MicroRNA Networks in Pancreatic Islet Cells: Normal Function and Type 2 Diabetes

Mir-101A and Mir-30B Contribute to Inflammatory Cytokine-Mediated Β-Cell Dysfunction

Plasma Mir-193b-3p is Elevated in Type 2 Diabetes and Could Impair Glucose Metabolism

Pancreatic Cells Control Glucose Homeostasis Via the Secretion of Exosomal Mir-29 Family

Mir-192 Is Upregulated In T1dm, Regulates Pancreatic -Cell Development And Inhibits Insulin Secretion Through Suppressing Glp-1 Expression

Retracted: MicroRNA‐30d Preserves Pancreatic Islet Β‐cell Function Through Negative Regulation of the JNK Signaling Pathway Via SOCS3 in Mice with Streptozotocin‐induced Diabetes Mellitus

Expression of miRNA-29 in Pancreatic β Cells Promotes Inflammation and Diabetes via TRAF3

Pancreatic β cells control glucose homeostasis via the secretion of exosomal miR-29 family

Cross-talks Between Micrornas and Mrnas in Pancreatic Tissues of Streptozotocin-Induced Type 1 Diabetic Mice

Microrna-503 Contribute to Pancreatic Beta Cell Dysfunction by Targeting the Mtor Pathway in Gestational Diabetes Mellitus.

Elevated miR-130a/miR130b/miR-152 expression reduces intracellular ATP levels in the pancreatic beta cell